Dier Mardi

Track

Insider profile

Performance

Overall performance
2.4
Performance over holding periods
2.4
30 days 90 days 120 days
Average return -12% 8.2% 15.1%
Success rate 26% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Dier Mardi's trades of Madrigal Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-06 2026-03-06
PlS Planned sale
92,422 +43.3%
30.74
US$960,355 		92,422 +43.3% 30.74 US$960,355
2026-03-06 2026-03-06
PlS Planned sale
1,928 -35.3%
384.27
US$3,315,424 		1,928 -35.3% 384.27 US$3,315,424
2026-03-06 2026-03-06
PlS Planned sale
14,788 -36.7%
291.54
US$2,759,536 		14,788 -36.7% 291.54 US$2,759,536
2026-03-06 2026-03-06
PlS Planned sale
160 -1.2%
434.20
US$69,472 		160 -1.2% 434.20 US$69,472
2026-03-06 2026-03-06
PlS Planned sale
116 -0.9%
432.56
US$50,176 		116 -0.9% 432.56 US$50,176
2026-03-06 2026-03-06
PlS Planned sale
120 -0.9%
430.90
US$51,708 		120 -0.9% 430.90 US$51,708
2026-03-06 2026-03-06
PlS Planned sale
40 -0.3%
429.58
US$17,183 		40 -0.3% 429.58 US$17,183
2026-03-06 2026-03-06
PlS Planned sale
160 -1.2%
429.00
US$68,639 		160 -1.2% 429.00 US$68,639
2026-03-06 2026-03-06
PlS Planned sale
80 -0.6%
427.85
US$34,228 		80 -0.6% 427.85 US$34,228
2026-03-06 2026-03-06
PlS Planned sale
420 -3.0%
426.86
US$179,283 		420 -3.0% 426.86 US$179,283
2026-03-06 2026-03-06
PlS Planned sale
40 -0.3%
425.08
US$17,003 		40 -0.3% 425.08 US$17,003
2026-03-06 2026-03-06
S Sale
646 -4.5%
431.94
US$279,033 		646 -4.5% 431.94 US$279,033
2026-03-06 2026-03-06
PrS Proposed sale
646
439.34
US$283,814 		646 439.34 US$283,814
2026-03-06 2026-03-06
PrS Proposed sale
1,336
439.34
US$586,958 		1,336 439.34 US$586,958
2026-03-02 2026-03-02
S Sale
1,183 -11.3%
427.21
US$505,389 		1,183 -11.3% 427.21 US$505,389
2026-03-02 2026-03-02
PrS Proposed sale
1,183
432.00
US$511,056 		1,183 432.00 US$511,056
2025-12-03 2025-12-02
PlS Planned sale
80 -0.8%
596.19
US$47,695 		80 -0.8% 596.19 US$47,695
2025-12-03 2025-12-02
PlS Planned sale
74 -0.7%
595.20
US$44,045 		74 -0.7% 595.20 US$44,045
2025-12-03 2025-12-02
PlS Planned sale
160 -1.5%
590.37
US$94,460 		160 -1.5% 590.37 US$94,460
2025-12-03 2025-12-02
PlS Planned sale
160 -1.5%
589.65
US$94,344 		160 -1.5% 589.65 US$94,344
2025-12-03 2025-12-02
PlS Planned sale
240 -2.2%
587.85
US$141,084 		240 -2.2% 587.85 US$141,084
2025-12-03 2025-12-02
PlS Planned sale
240 -2.1%
585.44
US$140,505 		240 -2.1% 585.44 US$140,505
2025-12-03 2025-12-02
PlS Planned sale
480 -4.0%
579.85
US$278,329 		480 -4.0% 579.85 US$278,329
2025-12-03 2025-12-02
PlS Planned sale
258 -2.1%
578.83
US$149,338 		258 -2.1% 578.83 US$149,338
2025-12-03 2025-12-02
PlS Planned sale
320 -2.6%
577.81
US$184,901 		320 -2.6% 577.81 US$184,901
2025-12-03 2025-12-02
PlS Planned sale
240 -1.9%
576.15
US$138,276 		240 -1.9% 576.15 US$138,276
2025-12-03 2025-12-02
PlS Planned sale
120 -0.9%
574.95
US$68,994 		120 -0.9% 574.95 US$68,994
2025-12-03 2025-12-02
PlS Planned sale
717 -5.3%
574.00
US$411,559 		717 -5.3% 574.00 US$411,559
2025-12-03 2025-12-02
PlS Planned sale
354 -2.5%
573.02
US$202,847 		354 -2.5% 573.02 US$202,847
2025-12-03 2025-12-02
PlS Planned sale
410 -2.9%
571.99
US$234,516 		410 -2.9% 571.99 US$234,516
2025-12-03 2025-12-02
PlS Planned sale
320 -2.2%
570.39
US$182,524 		320 -2.2% 570.39 US$182,524
2025-12-02 2025-12-02
PrS Proposed sale
4,173
579.45
US$2,418,045 		4,173 579.45 US$2,418,045
2025-03-12 2025-03-10
PlS Planned sale
258 -2.4%
323.04
US$83,344 		258 -2.4% 323.04 US$83,344
2025-03-03 2025-03-10
PrS Proposed sale
258
313.47
US$80,875 		258 313.47 US$80,875
2025-03-05 2025-03-03
PlS Planned sale
774 -10.1%
323.54
US$250,417 		774 -10.1% 323.54 US$250,417
2025-03-05 2025-03-03
S Sale
1,187 -13.4%
325.89
US$386,831 		1,187 -13.4% 325.89 US$386,831
2025-03-03 2025-03-03
PrS Proposed sale
774
323.54
US$250,417 		774 323.54 US$250,417
2025-03-03 2025-03-03
PrS Proposed sale
1,187
325.89
US$386,834 		1,187 325.89 US$386,834
2023-05-11 2023-05-09
US ACELYRIN Inc (SLRN)
B Purchase
875 +inf%
18.00
US$15,750 		875 +inf% 18.00 US$15,750
2023-05-11 2023-05-09
US ACELYRIN Inc (SLRN)
B Purchase
875 +inf%
18.00
US$15,750 		875 +inf% 18.00 US$15,750
2023-05-11 2023-05-09
US ACELYRIN Inc (SLRN)
B Purchase
5,556 +inf%
18.00
US$100,008 		5,556 +inf% 18.00 US$100,008
2022-10-17 2022-10-14
PlS Planned sale
1,629 -2.4%
40.16
US$65,421 		1,629 -2.4% 40.16 US$65,421
2022-10-14 2022-10-12
S Sale
3,484 -4.9%
38.22
US$133,158 		3,484 -4.9% 38.22 US$133,158
2022-03-03 2022-03-03
PlS Planned sale
420 -0.8%
64.55
US$27,111 		420 -0.8% 64.55 US$27,111
2022-03-03 2022-03-01
S Sale
534 -1.4%
66.62
US$35,575 		534 -1.4% 66.62 US$35,575